Pharmacists in Clinton, Arkansas


13 Pharmacists found in Clinton
female pharmacist

Dr. Andrea Michelle Brown, PHARMD


Pharmacist
1966 Highway 65 S, Clinton, AR 72031
501-745-2888    

female pharmacist

Annice Jean Craig, PHARMD


Pharmacist
129 Bone St, Clinton, AR 72031
501-745-4266     501-745-5707

male pharmacist

Darren Crymes, PHARMD


Pharmacist
2526 Highway 65 S, Clinton, AR 72031
501-745-8414    



male pharmacist

Jack Dowell Pittman Jr., DPH. GCP


Pharmacist - Geriatric
4134 Highway 336 W, Clinton, AR 72031
501-745-8784    

male pharmacist

Dr. Jacob Leslie, PHARMD


Pharmacist
2526 Highway 65 S Ste 101, Clinton, AR 72031
501-745-8414     501-745-8282

female pharmacist

Jodi Davis, PHARM D


Pharmacist
1966 Highway 65 S, Clinton, AR 72031
501-745-2888    

male pharmacist

Mr. Joshua Ray Langston, PHARM. D.


Pharmacist
129 Bone St, Clinton, AR 72031
501-745-4266     501-745-5707

female pharmacist

Julie Boxnick, PHARMD


Pharmacist
1966 Highway 65 S, Clinton, AR 72031
501-745-2888    

female pharmacist

Kirbi Chase Mcmullin, PHARMD


Pharmacist
1966 Highway 65 S, Clinton, AR 72031
501-745-2888    

female pharmacist

Kristen Riddle, PHARMD


Pharmacist
129 Bone St, Clinton, AR 72031
501-745-4266    

female pharmacist

Mrs. Marinda Renee Bryan, PHARMD


Pharmacist
2526 Hwy 65 S. Ste 101, Clinton, AR 72031
501-745-8414     501-745-8282

male pharmacist

Tommy W Shaw, PD


Pharmacist
1966 Highway 65 S, Clinton, AR 72031
501-745-2888    

female pharmacist

Dr. Whitney Leeann Holland, PHARMD


Pharmacist
1966 Highway 65 S, Clinton, AR 72031
501-745-2888     501-745-5028


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.